Cargando…
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Autores principales: | Geven, Christopher, Pickkers, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998508/ https://www.ncbi.nlm.nih.gov/pubmed/29895302 http://dx.doi.org/10.1186/s13054-018-2074-1 |
Ejemplares similares
-
Significance of adrenomedullin and the role of adrecizumab in sepsis
por: Nair, Abhijit
Publicado: (2021) -
Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats
por: Blet, Alice, et al.
Publicado: (2019) -
Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis
por: Geven, Christopher, et al.
Publicado: (2018) -
A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
por: Geven, Christopher, et al.
Publicado: (2019) -
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
por: van Lier, Dirk, et al.
Publicado: (2022)